102 related articles for article (PubMed ID: 25319435)
1. Therapeutic effects of amniotic fluid-derived mesenchymal stromal cells on lung injury in rats with emphysema.
Li Y; Gu C; Xu W; Yan J; Xia Y; Ma Y; Chen C; He X; Tao H
Respir Res; 2014 Oct; 15(1):120. PubMed ID: 25319435
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancer.
Li L; Wang D; Zhou J; Cheng Y; Liang T; Zhang G
PLoS One; 2015; 10(4):e0123350. PubMed ID: 25880317
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of pulmonary mesenchymal stem cells derived from rat fetal lung tissue.
Ma C; Liu Y; Ma Y; Jiang L; Huang Q; Liu G; Guo Y; Wang C; Liu C
Tissue Cell; 2021 Dec; 73():101628. PubMed ID: 34479072
[TBL] [Abstract][Full Text] [Related]
4. Amniotic fluid mesenchymal stem cells repair mouse corneal cold injury by promoting mRNA N4-acetylcytidine modification and ETV4/JUN/CCND2 signal axis activation.
Fei X; Cai Y; Lin F; Huang Y; Liu T; Liu Y
Hum Cell; 2021 Jan; 34(1):86-98. PubMed ID: 33010000
[TBL] [Abstract][Full Text] [Related]
5. Lung fibroblast-derived extracellular vesicles and soluble factors alleviate elastase-induced lung injury.
van der Koog L; Boerrigter MJ; Gorter IC; Gosens R; Nagelkerke A
Eur J Pharmacol; 2024 Jul; 974():176612. PubMed ID: 38677537
[TBL] [Abstract][Full Text] [Related]
6. Radiation Induces Pulmonary Fibrosis by Promoting the Fibrogenic Differentiation of Alveolar Stem Cells.
Wang LK; Wu TJ; Hong JH; Chen FH; Yu J; Wang CC
Stem Cells Int; 2020; 2020():6312053. PubMed ID: 33061990
[TBL] [Abstract][Full Text] [Related]
7. A gene therapy induced emphysema model and the protective role of stem cells.
Zarogoulidis P; Hohenforst-Schmidt W; Huang H; Sahpatzidou D; Freitag L; Sakkas L; Rapti A; Kioumis I; Pitsiou G; Kouzi-Koliakos K; Papamichail A; Papaiwannou A; Tsiouda T; Tsakiridis K; Porpodis K; Lampaki S; Organtzis J; Gschwendtner A; Zarogoulidis K
Diagn Pathol; 2014 Nov; 9():195. PubMed ID: 25394479
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific populations from amniotic fluid-derived mesenchymal stem cells manifest variant in vitro and in vivo properties.
Liu N; Cheng Y; Wang D; Guan H; Chen D; Zeng J; Lu D; Li Y; Yang Y; Luo Q; Zhu L; Jiang B; Sun X; Song B
Hum Cell; 2024 Mar; 37(2):408-419. PubMed ID: 38085460
[TBL] [Abstract][Full Text] [Related]
9. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration.
Nolen-Walston RD; Kim CF; Mazan MR; Ingenito EP; Gruntman AM; Tsai L; Boston R; Woolfenden AE; Jacks T; Hoffman AM
Am J Physiol Lung Cell Mol Physiol; 2008 Jun; 294(6):L1158-65. PubMed ID: 18375744
[TBL] [Abstract][Full Text] [Related]
10. The impact of the immune system on lung injury and regeneration in COPD.
Kapellos TS; Conlon TM; Yildirim AÖ; Lehmann M
Eur Respir J; 2023 Oct; 62(4):. PubMed ID: 37652569
[TBL] [Abstract][Full Text] [Related]
11. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers.
Vadasz S; Jensen T; Moncada C; Girard E; Zhang F; Blanchette A; Finck C
J Pediatr Surg; 2014 Nov; 49(11):1554-63. PubMed ID: 25475793
[TBL] [Abstract][Full Text] [Related]
12. Conversion of bone marrow mesenchymal stem cells into type II alveolar epithelial cells reduces pulmonary fibrosis by decreasing oxidative stress in rats.
Huang K; Kang X; Wang X; Wu S; Xiao J; Li Z; Wu X; Zhang W
Mol Med Rep; 2015 Mar; 11(3):1685-92. PubMed ID: 25411925
[TBL] [Abstract][Full Text] [Related]
13. Development of a new treatment for preterm birth complications using amniotic fluid stem cell therapy.
Abe Y; Sato Y; Tanaka M; Ochiai D
Histol Histopathol; 2023 Sep; 38(9):965-974. PubMed ID: 36971371
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Alveolar Type II Epithelial Cell Transplantation for Pulmonary Fibrosis: A Meta-Analysis.
Zhang W; Wang Y; Du Y; Li Z; Mu Y; Sun J; Liu Z; Guo Y; Shao H; Guan Y; Cui G; Du Z
Iran J Public Health; 2023 Jan; 52(1):1-9. PubMed ID: 36824257
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of miR-423-5p levels in chronic obstructive pulmonary disease patients.
Zhang X; Shi Q; Xiong L; Shi S; Li Y; Wang Y; Zhang M
Clinics (Sao Paulo); 2022; 77():100102. PubMed ID: 36162367
[TBL] [Abstract][Full Text] [Related]
16. Stem Cell-Based Regenerative Therapy and Derived Products in COPD: A Systematic Review and Meta-Analysis.
Calzetta L; Aiello M; Frizzelli A; Camardelli F; Cazzola M; Rogliani P; Chetta A
Cells; 2022 May; 11(11):. PubMed ID: 35681492
[TBL] [Abstract][Full Text] [Related]
17. Effect of mesenchymal stromal cell infusions on lung function in COPD patients with high CRP levels.
Weiss DJ; Segal K; Casaburi R; Hayes J; Tashkin D
Respir Res; 2021 May; 22(1):142. PubMed ID: 33964910
[TBL] [Abstract][Full Text] [Related]
18. An intra-amniotic injection of mesenchymal stem cells promotes lung maturity in a rat congenital diaphragmatic hernia model.
Takayama S; Sakai K; Fumino S; Furukawa T; Kishida T; Mazda O; Tajiri T
Pediatr Surg Int; 2019 Dec; 35(12):1353-1361. PubMed ID: 31559457
[TBL] [Abstract][Full Text] [Related]
19. Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema.
Lan YW; Yang JC; Yen CC; Huang TT; Chen YC; Chen HL; Chong KY; Chen CM
Stem Cell Res Ther; 2019 Jun; 10(1):163. PubMed ID: 31196196
[TBL] [Abstract][Full Text] [Related]
20. Cell-based Therapy for Chronic Obstructive Pulmonary Disease. Rebuilding the Lung.
Weiss DJ
Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S253-S259. PubMed ID: 30759002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
